Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/10/2025

ADHD Treatment Guidelines

Introduction to Treatment

  • The American Academy of Pediatrics recommends evidence-based parent and/or teacher-administered behavioral therapy as first-line treatment for children with ADHD, including parent training in behavior management and behavioral classroom interventions 1, 2
  • The American Academy of Pediatrics suggests considering methylphenidate as second-line treatment if behavioral interventions do not provide significant improvement, with a starting dose of 5 mg once or twice daily 2

Medication Treatment

  • The American Academy of Pediatrics recommends FDA-approved medications for ADHD, with the strongest evidence for stimulants (methylphenidate or amphetamine derivatives) and sufficient but less strong evidence for non-stimulants (atomoxetine, extended-release guanfacine, and extended-release clonidine) 2, 3
  • The recommended starting dose for methylphenidate is 5 mg twice daily (immediate-release) or 10 mg once daily (extended-release), with a maximum daily dose of 60 mg for adolescents 2
  • Medication doses should be titrated to achieve maximum benefit with minimum side effects 3

Behavioral Interventions

  • The American Academy of Pediatrics recommends concurrent behavioral interventions, including parent training in behavior management, behavioral classroom interventions, and educational supports (IEP or 504 plan) 2
  • Parent training and classroom management have median effect sizes of 0.55 and 0.61, respectively 3
  • Educational interventions, such as classroom accommodations, organizational skills training, and special education services, may be necessary for children with ADHD 3, 1, 2

Treatment Monitoring and Adjustment

  • Regular monitoring for side effects, including cardiovascular effects, weight changes, sleep disturbances, and development of tics or psychiatric symptoms, is essential for children with ADHD 2
  • Follow-up within 2-4 weeks after medication adjustments is recommended to assess effectiveness and side effects 2
  • Screening for and addressing comorbid conditions that may complicate treatment is crucial 3, 1, 2

Transition to Adult Care

  • The American Academy of Pediatrics recommends beginning transition planning to adult care at age 14 and recognizing ADHD as a chronic condition requiring ongoing management 2, 3
  • Periodically reevaluating the need for continued medication is necessary, and treating preschoolers with medication as first-line therapy is not recommended 3, 1, 2
  • Involving schools in treatment planning and providing educational interventions and teacher feedback are crucial components of effective ADHD management 1, 2